(Q35689005)

9 August 2017

1 reference

title

The pathogenesis of fibrosis and renal disease in scleroderma: recent insights from glomerulosclerosis (English)

1 reference

9 August 2017

1 reference

1 reference

Sungchun Lee

1

1 reference

9 August 2017

Sohee Lee

series ordinal

2

1 reference

9 August 2017

Kumar Sharma

series ordinal

3

1 reference

9 August 2017

publication date

1 April 2004

1 reference

Current Rheumatology Reports

9 August 2017

published in

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

141-148

1 reference

Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-004-0059-3

TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-004-0059-3

Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-004-0059-3

Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-004-0059-3

Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-004-0059-3

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-004-0059-3

21 January 2018

Scleroderma renal crisis

1 reference

12 December 2020

Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy

1 reference

12 December 2020

Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells

1 reference

12 December 2020

TGF-beta in kidney fibrosis: a target for gene therapy

1 reference

12 December 2020

Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?

1 reference

12 December 2020

Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction

1 reference

12 December 2020

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

12 December 2020

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

12 December 2020

Renal fibrosis and the renin-angiotensin system.

1 reference

12 December 2020

Relationship between underlying renal disease and renal transplantation outcome

1 reference

12 December 2020

Proinflammatory actions of angiotensins.

1 reference

12 December 2020

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

1 reference

12 December 2020

The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease

1 reference

12 December 2020

Renal transplantation in scleroderma

1 reference

12 December 2020

Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2

1 reference

12 December 2020

Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis

1 reference

12 December 2020

Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling.

1 reference

12 December 2020

18. Immune-mediated renal disease

1 reference

12 December 2020

Angiotensin II receptors.

1 reference

12 December 2020

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

1 reference

12 December 2020

Deficient Smad7 expression: a putative molecular defect in scleroderma

1 reference

12 December 2020

Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3

1 reference

12 December 2020

Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells

1 reference

12 December 2020

Angiotensin II and renal fibrosis.

1 reference

12 December 2020

Failure of losartan to control blood pressure in scleroderma renal crisis

1 reference

12 December 2020

Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts

1 reference

12 December 2020

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

12 December 2020

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

1 reference

12 December 2020

CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling

1 reference

12 December 2020

Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis

1 reference

12 December 2020

Renal transplantation for progressive systemic sclerosis with renal failure: case report and review of previous experience

1 reference

12 December 2020

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

1 reference

12 December 2020

Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension

1 reference

12 December 2020

Proteinases and glomerular matrix turnover

1 reference

12 December 2020

Normotensive renal failure in systemic sclerosis

1 reference

12 December 2020

Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis

1 reference

12 December 2020

Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway

1 reference

12 December 2020

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

1 reference

12 December 2020

PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation

1 reference

12 December 2020

Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement

1 reference

12 December 2020

Multi-faceted regulation of cell differentiation by extracellular matrix.

1 reference

12 December 2020

10.1007/S11926-004-0059-3

Identifiers

DOI

1 reference

9 August 2017

1 reference